Orgenesis Inc., a global biotech company working to unlock the full potential of cell and gene therapies, has appointed Luke Thorstenson as Director of Business Development. As Director of Business Development, his core responsibilities include setting the strategy for major Cell and Gene Therapy (CGT) initiatives and implementing the Orgenesis point-of-care platform in the United States. In addition, he will identify global opportunities for growth and analyze the development of value creation units and business units. He will also manage and establish new partnerships with research institutions like Johns Hopkins University, including the launch of several CGT specific facilities here in Baltimore
Born and raised in gang-infested South Central Los Angeles, I was surrounded by compassionate and risk-taking individuals who recognized and fertilized my love, talent, and academic prowess. Collectively my tribe, for it takes one to raise one, helped provide me with unimaginable opportunities to excel and continue the fight for an abundant life through health, social awareness, and artistic expression. I, a Man who is also Bold and Black, am a product of their courage, compassion, endurance, vision, and love – Stephen M. Jackson, PhD
Jacob Greenwood is the Director of Business Development in CRB’s Maryland office. Born and raised in Northeast Baltimore City, he is a life-long Marylander devoted to seeing his state prosper.
Adam Van Bavel Joins Workforce Genetics & BioBuzz to Lead Marketing & Business Development Workforce Genetics welcomes Adam Van Bavel as the new Head of Marketing and Business Development. Adam [….]
How Maryland’s Legacy Can Help Your Company Get the Most out of BIO 2018 As reported last week, BIO 2018 attracted more than 1,800 exhibitors and sponsors who took part [….]